Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation

Lung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates primarily due to late-stage diagnosis. Early detection can significantly improve survival rates, but lung cancer screening is not currently implemented in Italy. Many countries have implemented lung cancer s...

Full description

Bibliographic Details
Main Authors: Daniela Amicizia, Maria Francesca Piazza, Francesca Marchini, Matteo Astengo, Federico Grammatico, Alberto Battaglini, Irene Schenone, Camilla Sticchi, Rosa Lavieri, Bruno Di Silverio, Giovanni Battista Andreoli, Filippo Ansaldi
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/11/14/2085
_version_ 1797589112455168000
author Daniela Amicizia
Maria Francesca Piazza
Francesca Marchini
Matteo Astengo
Federico Grammatico
Alberto Battaglini
Irene Schenone
Camilla Sticchi
Rosa Lavieri
Bruno Di Silverio
Giovanni Battista Andreoli
Filippo Ansaldi
author_facet Daniela Amicizia
Maria Francesca Piazza
Francesca Marchini
Matteo Astengo
Federico Grammatico
Alberto Battaglini
Irene Schenone
Camilla Sticchi
Rosa Lavieri
Bruno Di Silverio
Giovanni Battista Andreoli
Filippo Ansaldi
author_sort Daniela Amicizia
collection DOAJ
description Lung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates primarily due to late-stage diagnosis. Early detection can significantly improve survival rates, but lung cancer screening is not currently implemented in Italy. Many countries have implemented lung cancer screening programs for high-risk populations, with studies showing a reduction in mortality. This review aimed to identify key areas for establishing a lung cancer screening program in Italy. A literature search was conducted in October 2022, using the PubMed and Scopus databases. Items of interest included updated evidence, approaches used in other countries, enrollment and eligibility criteria, models, cost-effectiveness studies, and smoking cessation programs. A literature search yielded 61 scientific papers, highlighting the effectiveness of low-dose computed tomography (LDCT) screening in reducing mortality among high-risk populations. The National Lung Screening Trial (NLST) in the United States demonstrated a 20% reduction in lung cancer mortality with LDCT, and other trials confirmed its potential to reduce mortality by up to 39% and detect early-stage cancers. However, false-positive results and associated harm were concerns. Economic evaluations generally supported the cost-effectiveness of LDCT screening, especially when combined with smoking cessation interventions for individuals aged 55 to 75 with a significant smoking history. Implementing a screening program in Italy requires the careful consideration of optimal strategies, population selection, result management, and the integration of smoking cessation. Resource limitations and tailored interventions for subpopulations with low-risk perception and non-adherence rates should be addressed with multidisciplinary expertise.
first_indexed 2024-03-11T01:01:43Z
format Article
id doaj.art-7d7e27812f2946c9ae6eb19e72b8bf32
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-03-11T01:01:43Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-7d7e27812f2946c9ae6eb19e72b8bf322023-11-18T19:33:47ZengMDPI AGHealthcare2227-90322023-07-011114208510.3390/healthcare11142085Systematic Review of Lung Cancer Screening: Advancements and Strategies for ImplementationDaniela Amicizia0Maria Francesca Piazza1Francesca Marchini2Matteo Astengo3Federico Grammatico4Alberto Battaglini5Irene Schenone6Camilla Sticchi7Rosa Lavieri8Bruno Di Silverio9Giovanni Battista Andreoli10Filippo Ansaldi11Regional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyRegional Health Agency of Liguria (ALiSa), 16121 Genoa, ItalyLung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates primarily due to late-stage diagnosis. Early detection can significantly improve survival rates, but lung cancer screening is not currently implemented in Italy. Many countries have implemented lung cancer screening programs for high-risk populations, with studies showing a reduction in mortality. This review aimed to identify key areas for establishing a lung cancer screening program in Italy. A literature search was conducted in October 2022, using the PubMed and Scopus databases. Items of interest included updated evidence, approaches used in other countries, enrollment and eligibility criteria, models, cost-effectiveness studies, and smoking cessation programs. A literature search yielded 61 scientific papers, highlighting the effectiveness of low-dose computed tomography (LDCT) screening in reducing mortality among high-risk populations. The National Lung Screening Trial (NLST) in the United States demonstrated a 20% reduction in lung cancer mortality with LDCT, and other trials confirmed its potential to reduce mortality by up to 39% and detect early-stage cancers. However, false-positive results and associated harm were concerns. Economic evaluations generally supported the cost-effectiveness of LDCT screening, especially when combined with smoking cessation interventions for individuals aged 55 to 75 with a significant smoking history. Implementing a screening program in Italy requires the careful consideration of optimal strategies, population selection, result management, and the integration of smoking cessation. Resource limitations and tailored interventions for subpopulations with low-risk perception and non-adherence rates should be addressed with multidisciplinary expertise.https://www.mdpi.com/2227-9032/11/14/2085lung cancerscreening programlow-dose computed tomography (LDCT)cost-effectivenessmortality reductionhealthcare
spellingShingle Daniela Amicizia
Maria Francesca Piazza
Francesca Marchini
Matteo Astengo
Federico Grammatico
Alberto Battaglini
Irene Schenone
Camilla Sticchi
Rosa Lavieri
Bruno Di Silverio
Giovanni Battista Andreoli
Filippo Ansaldi
Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
Healthcare
lung cancer
screening program
low-dose computed tomography (LDCT)
cost-effectiveness
mortality reduction
healthcare
title Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
title_full Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
title_fullStr Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
title_full_unstemmed Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
title_short Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
title_sort systematic review of lung cancer screening advancements and strategies for implementation
topic lung cancer
screening program
low-dose computed tomography (LDCT)
cost-effectiveness
mortality reduction
healthcare
url https://www.mdpi.com/2227-9032/11/14/2085
work_keys_str_mv AT danielaamicizia systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT mariafrancescapiazza systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT francescamarchini systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT matteoastengo systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT federicogrammatico systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT albertobattaglini systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT ireneschenone systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT camillasticchi systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT rosalavieri systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT brunodisilverio systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT giovannibattistaandreoli systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation
AT filippoansaldi systematicreviewoflungcancerscreeningadvancementsandstrategiesforimplementation